Tag: Immune mediated colitis

Studies show that immune-related adverse events (irAEs), including diarrhea and colitis, can affect a significant percentage of patients receiving immunotherapy. Understanding **how to stop diarrhea from immunotherapy?** is crucial for managing these side effects effectively and ensuring treatment continuity. The first step is always to communicate with your oncology care team.

While the overall incidence of ocrelizumab-induced colitis is estimated to be low at around 0.018%, it is a recognized serious side effect. Knowing **what are the symptoms of Ocrevus colitis** is crucial for patients undergoing this Multiple Sclerosis (MS) treatment.